Journal: Cell Communication and Signaling : CCS
Article Title: Intermittent fasting promotes plaque regression and activates the BMAL1–MERTK efferocytosis axis
doi: 10.1186/s12964-026-03140-3
Figure Lengend Snippet: Mertk mediates Bmal1-dependent preservation of macrophage efferocytosis under lipid stress and supports a proposed working model of plaque remodeling. A , B Representative images ( A ) and quantification ( B ) of efferocytosis in BMDMs under untreated control conditions, oxidized low-density lipoprotein (ox-LDL) exposure, ox-LDL plus Bmal1 knockdown, or ox-LDL plus Bmal1 knockdown with Mertk re-expression. C , D Complementary gain-of-function and inhibitor experiment under untreated control conditions, ox-LDL exposure, ox-LDL plus Bmal1 overexpression, or ox-LDL plus Bmal1 overexpression with the Mertk/FLT3 kinase inhibitor MRX-2843 (150 nM; 2-h pretreatment). Apoptotic Jurkat targets were labeled with CFDA-SE (green), BMDMs with CMTPX (red), and nuclei with DAPI (blue). Scale bar, 50 μm; the bar shown at the lower left of A applies to both A and C. The efferocytosis index was the percentage of red macrophages containing at least one internalized green apoptotic target. For each condition, BMDMs isolated separately from three donor mice were maintained in three donor-specific culture dishes, with each dish constituting one biological replicate ( n = 3). Two completely nonoverlapping fields were acquired from each dish and retained as separate field-level measurements; therefore, six points are shown per condition (two fields nested within each of three biological replicates). Data are mean ± SEM and were analyzed by one-way ANOVA followed by Tukey's multiple-comparison test. All reported experimental-comparison P values are two-sided. *** P < 0.001. E Proposed working model integrating human systems-genetic candidate prioritization with the mouse plaque-remodeling phenotype and macrophage experiments. The functional Bmal1–Mertk dependency was established in cultured macrophages; its contribution to the complete in vivo response to IF remains a proposed link that requires macrophage-specific genetic validation. CFDA-SE, carboxyfluorescein diacetate succinimidyl ester; CMTPX, CellTracker Red CMTPX
Article Snippet: The dual Mertk/FLT3 kinase inhibitor MRX-2843 (Cat# T16144 ; TargetMol) was used for pharmacological inhibition.
Techniques: Preserving, Control, Knockdown, Expressing, Over Expression, Labeling, Isolation, Comparison, Functional Assay, Cell Culture, In Vivo, Biomarker Discovery, In Vitro